FI972185A0 - Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon - Google Patents

Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon

Info

Publication number
FI972185A0
FI972185A0 FI972185A FI972185A FI972185A0 FI 972185 A0 FI972185 A0 FI 972185A0 FI 972185 A FI972185 A FI 972185A FI 972185 A FI972185 A FI 972185A FI 972185 A0 FI972185 A0 FI 972185A0
Authority
FI
Finland
Prior art keywords
treatment
insulin
aminoguanidine
carboxylate
diabetes mellitus
Prior art date
Application number
FI972185A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972185A (fi
Inventor
Scott D Larsen
Valerie A Vaillancourt
Paul D May
Steven P Tanis
John A Tucker
Martin D Meglasson
Heinrich J Schostarez
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI972185A publication Critical patent/FI972185A/fi
Publication of FI972185A0 publication Critical patent/FI972185A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI972185A 1994-11-23 1997-05-22 Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon FI972185A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
FI972185A FI972185A (fi) 1997-05-22
FI972185A0 true FI972185A0 (fi) 1997-05-22

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972185A FI972185A0 (fi) 1994-11-23 1997-05-22 Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon

Country Status (24)

Country Link
US (2) US6166080A (et)
EP (1) EP0793646B1 (et)
JP (1) JPH10509455A (et)
CN (2) CN1097580C (et)
AT (1) ATE205188T1 (et)
AU (1) AU705893B2 (et)
BR (1) BR9509741A (et)
CA (1) CA2202265A1 (et)
CZ (1) CZ288597B6 (et)
DE (2) DE793646T1 (et)
DK (1) DK0793646T3 (et)
EE (1) EE03392B1 (et)
ES (1) ES2163531T3 (et)
FI (1) FI972185A0 (et)
GE (1) GEP20002026B (et)
HU (1) HUT77133A (et)
MX (1) MX9703807A (et)
NO (1) NO308992B1 (et)
NZ (1) NZ297604A (et)
PL (1) PL184614B1 (et)
PT (1) PT793646E (et)
RU (1) RU2162462C2 (et)
SK (1) SK282357B6 (et)
WO (1) WO1996016031A1 (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
US5955617A (en) * 1996-05-21 1999-09-21 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
CA2280871A1 (en) * 1997-02-13 1998-08-20 Valerie Piercy Use of nitric oxide synthase inhibitors for the treatment of diabetes
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
EP2283349A1 (en) * 2008-04-29 2011-02-16 Becton, Dickinson & Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
MX2011000135A (es) * 2008-06-26 2011-02-25 Silanes Sa De Cv Lab Una nueva sal de glicinato de metformina para el control de la glucosa en sangre.
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
EP3196271B1 (en) * 2015-04-23 2019-01-09 Mitsubishi Gas Chemical Company, Inc. Gas-generating agent, and process for producing foamed object using same
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
CN1097580C (zh) 2003-01-01
AU4279696A (en) 1996-06-17
NO308992B1 (no) 2000-11-27
NO972346L (no) 1997-07-23
NO972346D0 (no) 1997-05-22
PL184614B1 (pl) 2002-11-29
CA2202265A1 (en) 1996-05-30
BR9509741A (pt) 1997-10-21
DE69522580D1 (de) 2001-10-11
EE9700094A (et) 1997-10-15
JPH10509455A (ja) 1998-09-14
CN1377642A (zh) 2002-11-06
DE793646T1 (de) 1999-12-30
CN1164226A (zh) 1997-11-05
GEP20002026B (en) 2000-04-10
SK64097A3 (en) 1997-11-05
WO1996016031A1 (en) 1996-05-30
EE03392B1 (et) 2001-04-16
US6166080A (en) 2000-12-26
DE69522580T2 (de) 2002-10-10
US6329545B1 (en) 2001-12-11
ES2163531T3 (es) 2002-02-01
CZ136997A3 (cs) 1998-02-18
EP0793646B1 (en) 2001-09-05
CZ288597B6 (cs) 2001-07-11
FI972185A (fi) 1997-05-22
EP0793646A1 (en) 1997-09-10
RU2162462C2 (ru) 2001-01-27
SK282357B6 (sk) 2002-01-07
NZ297604A (en) 2000-07-28
DK0793646T3 (da) 2001-12-17
AU705893B2 (en) 1999-06-03
HUT77133A (hu) 1998-03-02
MX9703807A (es) 1997-08-30
PL320361A1 (en) 1997-09-29
ATE205188T1 (de) 2001-09-15
PT793646E (pt) 2002-03-28

Similar Documents

Publication Publication Date Title
FI972185A0 (fi) Aminoguanidiinikarboksylaatit insuliinista riippumaton diabeteksen hoitoon
ATE131863T1 (de) Verwendung von halogenkohlenwasserstofflösungsmittel als reinigungsmittel
AU6613896A (en) Chemical compounds
DE69519207T2 (de) Kautschukzusammensetzung ohne Gehalt an carcinogenen Nitrosaminvorläufern, die als Verbindungsgummi geeignet ist
GB9201857D0 (en) Novel compound
DE69432140D1 (de) Verfahren zur Herstellung von 9-Desoxotaxanen
DE59100594D1 (de) Austraggerät zur Bedienung von Doppelkartuschen.
EP0330041A3 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
FI951511A (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
GB9206768D0 (en) New compounds for use in the treatment of cancer
AU648285B2 (en) Coating material, process for producing it and its use
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
ATE196631T1 (de) Xamonelin-tartrat
ES8601226A1 (es) Procedimiento para preparar fenoxialquilfosfinatos y fosfonatos
AU3854097A (en) Thienylcyclohexane derivatives for thienylcyclohexyl synthesis
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
IT216599Z2 (it) Attrezzo manuale, per lo svolgimento ed il tensionamento di film flessibele da bobina.
MX9802104A (es) Composiciones que usan un agonista de rxr solo o en combinacion con un agonista de ppar, para tratar diabetes mellitus no dependiente de insulina.
TH4208B (th) สารประกอบอิมิดาโซล และสารผสมสำหรับฆ่าจุลินทรีย์ซึ่งประกอบด้วยสารชนิดเดียวกันนั้น สำหรับควบคุมอนินทรีย์ที่เป็นอันตราย